Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon tells Proactive's Stephen Gunnion that the company has landed a healthcare contract worth more than £600,000 annually with an international blue-chip client — a significant step in its push into higher-margin markets.
"We see healthcare, defence and medical as being the higher margin markets," Deacon says, outlining a deliberate shift away from customer concentration in pest control toward sectors that offer better returns and larger international partners.
The contract electronics manufacturing division is also playing a broader role within the group, supporting AgTech product manufacturing and creating new opportunities following the Injectaclad acquisition — positioning Light Science as an increasingly integrated business rather than a collection of separate divisions.
Watch the full interview to hear more about Light Science Technologies’ growth strategy, international opportunities and focus on improving margins across its divisions.
For more videos like this, visit the Proactive YouTube channel, give this video a like, subscribe to the channel and enable notifications so you never miss future content.
#LightScienceTechnologies #SimonDeacon #HealthcareSector #CEM #ElectronicsManufacturing #AgTech #DefenseSector #MedicalTechnology #Manufacturing #PassiveFireProtection #Investing #UKStocks #ProactiveInvestors #BusinessGrowth #HealthcareTechnology
